Adrenocortical carcinoma surgery

Revision as of 14:50, 21 September 2017 by Medhat (talk | contribs)
Jump to navigation Jump to search

Adrenocortical carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenocortical carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

MRI

CT

Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation Therapy

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Adrenocortical carcinoma surgery On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenocortical carcinoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenocortical carcinoma surgery

CDC on Adrenocortical carcinoma surgery

Adrenocortical carcinoma surgery in the news

Blogs on Adrenocortical carcinoma surgery

Hospitals Treating Adrenocortical carcinoma

Risk calculators and risk factors for Adrenocortical carcinoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Surgery is the mainstay of treatment for adrenocortical carcinoma.

Surgery

  • Surgery is the mainstay of treatment for adrenocortical carcinoma.
  • Surgery can also be performed even in the case of the invasion into large blood vessels, such as the renal vein or inferior vena cava.
  • A large percentage of patients are not surgical candidates.

Appropriate preoperative evaluation and operative planning are the most important to assure the best outcome.

Preoperative imaging should be obtained to evaluate the extent of the tumor.

Imaging should be done just before the surgery because ACC grow quickly and involvement of adjacent structures may change

Optimization of hormone excess in patients with functional masses especially those with Cushing’s syndrome

Patients widespread distant metastatic disease in multiple organs or those with multiple metastatic deposits in one organ system unable to be completely resected should not undergo adrenalectomy.

The primary tumor can instead be treated with external beam radiation for palliation along with other adjuncts to improve local symptoms and better control hormone excess,

if present (247).

Obstruction of the vena cava by tumor thrombus can lead to significant lower body edema, which leads to significant patient suffering. If tumor resection is not technically operable, vena cava stents can be placed, leading to temporary prevention of occlusion.

Debulking for control of hormone excess in the setting of known metastatic disease is also performed in some situations. The benefits of debulking must outweigh the risks of surgery in these patients who have poor wound healing and lengthy recovery periods due to preexisting debilitation

References

Template:WikiDoc Sources